BPG is committed to discovery and dissemination of knowledge
Minireviews Open Access
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
World J Crit Care Med. Mar 9, 2026; 15(1): 113252
Published online Mar 9, 2026. doi: 10.5492/wjccm.v15.i1.113252
Minimizing hospital acquired intensive care unit infections: A focus on prevention
Marco Sanvitti, Department of Pediatric Surgery, "Sapienza" University of Rome, Rome 00185, Lazio, Italy
Laurynas Kanapeckas, Department of Neurosurgery, Lithuanian University of Health Sciences Kaunas Clinics, Kaunas 50161, Kauno Miestas, Lithuania
Federico Bilotta, Department of Anesthesiology and Intensive Care, University of Tor Vergata, Rome 00133, Lazio, Italy
ORCID number: Marco Sanvitti (0009-0008-7555-4872); Federico Bilotta (0000-0003-2496-6646).
Author contributions: Sanvitti M was the first author, responsible for conceptualizing and designing the review, conducting the literature search, analyzing and interpreting the data, and drafting the original manuscript; Kanapeckas L assisted with data extraction, literature review, and manuscript preparation; Bilotta F served as the senior author, supervising the project, providing critical revisions, and overseeing the overall direction of the work; all authors contributed to manuscript drafting and approved the submitted version.
Conflict-of-interest statement: There is no conflict of interest associated with any of the senior author or other coauthors contributed their efforts in this manuscript.
Corresponding author: Federico Bilotta, MD, PhD, Professor, Department of Anesthesiology and Intensive Care, University of Tor Vergata, Via Cracovia 50, Rome 00133, Lazio, Italy. bilotta@tiscali.it
Received: August 20, 2025
Revised: September 23, 2025
Accepted: December 3, 2025
Published online: March 9, 2026
Processing time: 192 Days and 17.5 Hours

Abstract

Hospital-acquired infections (HAIs) are a leading cause of morbidity and mortality in intensive care units (ICUs), largely driven by invasive devices, immunosuppression, and prolonged hospitalization. Despite available guidelines, prevention strategies remain inconsistently applied across settings. This narrative review synthesized evidence from PubMed (2020-2025) and key guideline documents (World Health Organization, Centers for Disease Control and Prevention, Infectious Diseases Society of America, Society for Healthcare Epidemiology of America), focusing on staff-level, patient-level, and systemic interventions for ICU infection prevention. Eligible sources included systematic reviews, clinical trials, consensus statements, and implementation studies. Effective staff-level strategies include strict hand hygiene, correct use of personal protective equipment, vaccination, and decontamination of personal devices, supported by audits and feedback. Patient-level care bundles targeting ventilator-associated pneumonia, central line-associated bloodstream infection, and catheter-associated urinary tract infection reduce device-related complications, though real-world adherence varies. Systemic measures such as closed ICU models, adequate nurse-to-patient ratios, triage protocols, and single-patient rooms, further mitigate infection risks. Implementation barriers include resource limitations, compliance gaps, and ethical considerations regarding futile care. Preventing ICU-acquired infections requires coordinated, multifaceted strategies embedded into daily practice. Sustained progress depends on leadership, continuous education, auditing, and adaptation of international frameworks to local contexts.

Key Words: Hospital-acquired infection; Intensive care units; Infection control; Care bundles; Hand hygiene; Device-associated infection

Core Tip: Hospital-acquired infections remain frequent in intensive care units (ICUs), contributing to excess mortality, prolonged hospitalization, and higher costs. Evidence shows that adherence to hand hygiene, staff vaccination, and device-care bundles can substantially reduce ventilator-associated pneumonia, bloodstream, and urinary tract infections. Systemic measures such as adequate nurse-to-patient ratios, single-patient rooms, and closed ICU models further improve outcomes. This review integrates staff-level, patient-level, and organizational strategies, highlighting that effective prevention requires not only technical measures but consistent implementation, monitoring, and adaptation across different healthcare settings to achieve sustainable reductions in infection rates.



INTRODUCTION

Hospital-acquired infections (HAIs) are a major concern in intensive care units (ICUs), where critically ill patients face a heightened risk due to frequent use of invasive devices, immunosuppression, and prolonged hospitalization[1]. The most common pathogens associated with ICU-acquired infection are gram-negative bacteria, among these, Klebsiella species are frequently identified as the leading pathogen, followed closely by Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter species[2]. The prevalence of ICU-acquired infections is estimated at approximately 22%, with a significant impact on patient outcomes[3]. Compared to community-acquired infections, they are associated with increased mortality, with an odds ratio (OR) of 1.32. These infections also contribute to prolonged ICU and hospital stays: Patients with ICU-onset bloodstream infections have a median ICU stay of 13 days, compared to 5 days for those with infections present on admission[4]. The resulting healthcare burden is substantial, driven by longer hospitalizations, increased antibiotic use, and the need for additional medical interventions[5].

Preventing ICU-acquired infections hinges on a structured approach that integrates clinical protocols, behavioral discipline, and organizational culture[6]. Sustained prevention depends less on isolated measures and more on embedding infection control within everyday clinical routines[7]. This requires not only equipping healthcare professionals with up-to-date knowledge but fostering a collective sense of accountability within the care team[8]. Institutional commitment to continuous education, quality improvement, and monitoring of outcomes is essential to ensure that prevention efforts translate into real-world practice[6,9].

Implementation of evidence-based infection prevention strategies has been shown to significantly decrease the incidence of HAIs and their complications, with the Centers for Disease Control and Prevention (CDC) reporting a 58% reduction in central line associated blood stream infections (CLABSI) rates in ICUs following widespread adoption of prevention protocols[5]. By reducing the incidence of infections, initiatives targeting HAI prevention in ICUs have demonstrated overall healthcare savings of $68.8 million and a return on investment of 765% over three years[10].

The evidence base for ICU infection prevention remains incomplete. Implementation of preventive strategies is inconsistent across institutions, with variable adherence and limited generalizability to different resource settings[11]. Evidence on the long-term sustainability of infection control programs is limited[12], and the lack of high-quality studies from low- and middle-income countries restricts their global applicability[13].

Although several guidelines from different institutions, such as World Health Organization (WHO) and CDC, provide frameworks for infection prevention, there remains a lack of recent reviews synthesizing evidence across staff-level, patient-level, and systemic strategies within a single framework. Previous reports have primarily emphasized single interventions rather than integrated approaches. This narrative review aims to provide a comprehensive report synthesizing practical insights based on available clinical evidence on prevention of HAIs in the ICU.

METHODS

This work was conducted as a narrative review with the objective of synthesizing contemporary evidence on strategies to prevent HAIs in ICUs. A structured search was performed in PubMed, which was considered the most comprehensive biomedical database for the subject. The core search string combined the following key terms: “ICU infection prevention”, “hospital-acquired infection”, “healthcare-associated infection”, “infection control”, and “intensive care unit”. To capture intervention-specific evidence, we employed a broad set of secondary terms, including “hand hygiene”, “personal protective equipment”, “healthcare worker vaccination”, “staff attire”, “device contamination”, “ventilator-associated pneumonia”, “central line-associated bloodstream infection”, “catheter-associated urinary tract infection”, “care bundles”, “audit and feedback”, “closed ICU model”, “nurse-to-patient ratio”, “single-patient rooms”, and “futile care”. Boolean operators (AND, OR) were applied to refine the retrieval strategy. The search focused on publications between January 2020 and August 2025, ensuring inclusion of the most recent clinical guidelines, systematic reviews, and implementation studies. Earlier seminal references were incorporated selectively when necessary to provide historical context (e.g., WHO “5 Moments of Hand Hygiene”). Eligible sources included systematic reviews, meta-analyses, randomized controlled trials, prospective and retrospective cohort studies, consensus statements, and guideline documents. Only peer-reviewed articles published in English were considered.

INFECTION PREVENTION IN ICU

This section discusses preventive measures intended to reduce the incidence of ICU acquired infection. Three major topics related to ICU infection prevention will be addressed: Staff level precautions, patient-focused interventions and systemic institutional measures.

Staff-level precautions

Key measures for ICU infection prevention include hand hygiene, personal protective equipment (PPE), up-to-date immunizations, decontamination of personal devices, and adherence to attire standards (Table 1). These practices, reinforced through structured training, audits, and feedback, can effectively reduce the risk of infection transmission.

Table 1 Staff-level infection prevention strategies and key components.
Strategy
Key components
Hand hygieneWHO 5 Moments framework, audits, alcohol-based rub availability, behavioral nudges
Personal protective equipment (PPE)Proper donning and doffing techniques, use during high transmission or aerosol-generating procedures
ImmunizationsEnsure all ICU personnel are vaccinated against transmissible diseases (e.g., influenza, hepatitis B)
Device decontaminationRegular cleaning of mobile phones and stethoscopes
Attire standardsShort sleeves, no rings or watches, daily uniform change
Structured protocolTraining, audits, and feedback to improve compliance

Hand hygiene is the single most important measure to prevent HAIs in ICUs, yet adherence remains suboptimal, with a global compliance average of 59.6%, ranging from 64.5% in high-income to 9.1% in low-income countries[14]. Compliance temporarily improved during the coronavirus disease 2019 (COVID-19) pandemic, rising from 54.5% to 70.1%[15], but declined post-pandemic[16]. Lower compliance is particularly observed among consultants and non-ICU staff compared to ICU nurses[17,18]. The WHO’s “5 Moments of Hand Hygiene” remains the cornerstone framework, advising hygiene before touching a patient, before clean/aseptic procedures, after body fluid exposure/risk, after touching a patient, and after touching a patient's surroundings[19]. The Infectious Diseases Society of America (IDSA), together with Society for Healthcare Epidemiology of America (SHEA) and Association for Professionals in Infection Control and Epidemiology (APIC), recommends combining alcohol-based rub at point-of-care, unit-specific education, electronic or direct monitoring with feedback, and leadership engagement[20]. Complementary behavioral interventions, including co-designed visual cues and motivational nudges at key failure points, further improve compliance when staff are actively involved[21].

PPE plays a critical role in minimizing infection transmission in ICU. Its effectiveness is highly dependent on correct donning and doffing, as observational studies show that improper technique frequently causes self-contamination[22]. Following standardized protocols from WHO and CDC substantially reduces these failures[23]. Use of respirators is particularly important when community transmission of respiratory viruses is high, when caring for patients with suspected or confirmed infection, or during aerosol-generating procedures[24,25].

Personal immunization of ICU personnel is essential to prevent nosocomial transmission of infectious diseases. Healthcare workers are at risk of both acquiring and transmitting influenza, measles, mumps, rubella, varicella, pertussis, and hepatitis B[26]. Vaccination not only protects healthcare workers themselves but also reduces spread to patients and colleagues[27,28]. In Italian hospitals, the incidence of COVID-19 infection was 4.88 cases per 100000 person-days among vaccinated staff compared to 103.55 among non-vaccinated, corresponding to a 95% reduction in risk[29]. Whether healthcare facilities should recruit only vaccinated staff or provide vaccination after hiring remains debated[28]. Recruitment policies vary globally, but on-site vaccination programs at employment entry are essential to ensure full coverage of ICU personnel[30,31].

Additional strategies target contamination of personal equipment. Nearly all healthcare workers’ mobile phones harbor potentially pathogenic and antibiotic-resistant bacteria, as well as fungi and viruses[32-34]. Stethoscopes show contamination rates exceeding 80%, often with S. aureus, Pseudomonas, and Klebsiella[35,36]. Best attire practices include wearing short-sleeved scrubs, avoiding wristwatches and rings, and changing uniforms daily These measures reduce microbial load and limit the transfer of multidrug-resistant organisms between patients and the ICU environment[37-39].

A structured protocol based on staff training, auditing, and feedback is necessary to implement these precautions. Standardized training for ICU staff on infection prevention improves adherence to best practices and improves infection control behaviors and patient safety[40]. Providing structured feedback to staff based on audit results is another critical component. Feedback should be specific, actionable, and delivered in a supportive manner to reinforce correct behaviors and address deficiencies. Studies show that combining education, audit, and feedback leads to significant reductions in ICU-acquired infections[41,42]. In a prospective study in COVID ICUs, implementation of structured hand hygiene auditing with timely feedback increased total adherence from 26.7% to 68.4% over six months, with an overall compliance rate of 65.3%. Improved adherence correlated with a reduction in device-associated infection rates from 24.7 to 11.5 per 1000 device days[43].

Patient-level precautions

This section will summarize the three main care bundles used in the ICU to reduce risk of infection in patients (Table 2): Ventilator care bundle, central line care bundle and urinary catheter care bundle.

Table 2 Patient-level infection prevention strategies and key components.
Strategy
Key components
VAP bundleMinimized sedation, daily sedation interruption, oral care without chlorhexidine, early mobilization, head-of-bed elevation
CLABSI bundleSterile PPE, chlorhexidine skin prep, subclavian access, chlorhexidine dressings, insertion and maintenance auditing
CAUTI bundleUse catheter only when necessary, aseptic insertion by trained staff, smallest catheter size, daily reassessment and prompt removal

Patients in the ICU frequently undergo invasive procedures such as mechanical ventilation (MV) and placement of central venous lines, to reduce the complications associated with these techniques care bundles were implemented[44]. A care bundle is defined as a set of evidence-based practices or interventions that, when performed collectively and reliably, are intended to improve patient outcomes and the quality of care for a specific clinical condition or procedure[45]. Before their implementation, the standard practice to prevent infection spread in healthcare settings relied on individual, often isolated, evidence-based interventions rather than a coordinated, systematic approach[46].

Ventilator associated pneumonia (VAP) is a serious complication during MV, with an incidence up to 30% in ICU patients undergoing MV[47]. To reduce this risk, VAP care bundles were put into place in different institutions. The IDSA, in its 2022 guideline, highlights the most consistently supported elements for VAP prevention[48]. Minimizing sedation whenever possible is advised, with a strong preference for non-benzodiazepine agents, such as dexmedetomidine or propofol, as these are associated with shorter durations of MV and ICU stay[49]. Daily sedation interruption and assessment of readiness to extubate are other key elements, as these interventions are independently associated with less time to extubation and lower ventilator mortality[48]. Oral care with toothbrushing, but without the use of chlorhexidine has also been associated with lower rates of hospital-acquired pneumonia, including VAP, as well as reductions in ICU mortality, ICU length of stay, and days of MV[50]. Early exercise and mobilization have been shown to shorten the duration of MV, reduce ICU length of stay and lower VAP rates[51]. At least one physical therapy session per day, three days per week, is recommended[52]. Another component of the VAP bundle is a head of bed elevation between 30-45 degrees. A 2024 systematic review and meta-analysis of six randomized trials demonstrated that head-of-bed elevation at 45° significantly decreased the incidence of ventilator-associated pneumonia compared with 30° (OR = 0.51, 95%CI: 0.31-0.84; P < 0.05)[53]. However, minimizing sedation and reducing prolonged intubation are not without risks. Reported complications include an increased incidence of unplanned extubations and potential subglottic stenosis[54,55]. Similarly, positioning strategies such as elevating the head of the bed to 45°, although effective in reducing ventilator-associated pneumonia, have been associated with nearly double the risk of pressure ulcer development (OR = 1.95, 95%CI: 1.12-3.37; P < 0.05)[53]. These examples underscore the need to balance infection prevention with patient safety and individualized care.

CLABSI are another serious complication in the ICU setting, with an estimated incidence of 1-6 per 1000 catheter-days[56]. In their 2022 practice recommendations SHEA/IDSA/APIC described the optimal interventions to reduce this risk[57]. This bundle approach focuses on both catheter insertion and maintenance components. Provider hygiene and the use of sterile PPE, as outlined in its dedicated section, is of paramount importance during catheter insertion, as well as patients skin preparation with an alcoholic chlorhexidine solution[5]. The subclavian site is preferred over other central venous access sites in the ICU setting to reduce infectious complications. Compared to the femoral and internal jugular sites, the subclavian site includes a lower density of skin flora and a longer subcutaneous tract, both of which decrease the likelihood of microbial entry and catheter colonization[58]. After insertion, the use of chlorhexidine-containing dressings has been associated with a sustained and significant reduction in catheter-associated bloodstream infection rates[59]. Surveillance and auditing of CLABSI rates are another essential part to reduce the incidence of infections[60].

Catheter-associated urinary tract infections (CAUTI) have an estimated incidence of 1.2-7.8 per 1000 catheter days in adult ICUs[61]. The absolute mortality difference for CAUTI in ICU patients is approximately 9.9%, compared to 29.0% for VAP and 31.6% for CLABSI[62], but it is regardless independently associated with increased mortality[63]. This subject was addressed in the 2022 practice recommendations by SHEA/IDSA/APIC, highlighting different essential practices that should be put into place[64]. Urinary catheters should be inserted only when necessary for patient care in ICU patients, removed as soon as indications no longer exist, and assessed daily for ongoing necessity to minimize the risk of CAUTI[65]. It must be ensured that only trained providers proceed with catheter insertion[66] and the use of aseptic technique and sterile equipment for catheter insertion is advised[67]. The smallest feasible urinary catheter size should be used to minimize trauma, this should be done to avoid mucosal injury from larger catheters or repeated attempts, which facilitates bacterial entry and colonization[68].

Despite their proven efficacy, implementation of care bundles in real-world ICU practice is often constrained by contextual challenges. In high-income settings, adherence is threatened by staff workload, burnout, and variable compliance with daily protocols[69], while in low- and middle-income countries resource limitations such as shortages of sterile equipment, limited access to trained personnel, and overcrowding reduce feasibility and sustainability[70]. Even when bundles are applied, balancing infection prevention with patient safety requires constant vigilance, as illustrated by complications like unplanned extubations or pressure ulcers associated with sedation minimization and head-of-bed elevation[71]. These examples highlight that the success of patient-level bundles depends not only on technical design but also on organizational culture, staff engagement, and continuous auditing to ensure translation into consistent clinical practice[72,73].

To summarize, prevention of VAP, CLABSI, and CAUTI begins with ensuring that invasive devices are used only when clinically indicated. Daily reassessment of their necessity is essential, with prompt removal as soon as the patient is ready, to reduce the duration of exposure and the associated infection risk[48,57,64]. However, their real-world effectiveness is often constrained by barriers such as resource limitations, variability in staff compliance, and the need for sustained auditing and feedback to ensure consistent application.

Systemic precautions

This section will summarize different precautions that can be implemented on a systemic level (Table 3): Futile care, ICU models, single patient rooms, nurse-to-patient ratios, palliative care, early goal discussions and nursing staff roles.

Table 3 Systemic infection prevention strategies and details.
Strategy
Details
ICU triage and admission protocolsAvoid futile care and reduce overcrowding
Closed ICU model24/7 oversight by intensivist-led team
Single patient roomsReduce MDRO transmission
Nurse-to-patient ratiosImprove care quality and reduce infection risk
Palliative care and early goal discussionsLimit non-beneficial interventions and exposure to infection

Beyond already discussed personal precautions by healthcare staff and bedside protocols, systemic infection prevention measures must be taken to reduce infection spread. A study by Vincent et al[74] presents strong evidence that the risk of infection increases with ICU admission and especially with longer ICU stays. Additionally, according to a study by Huynh et al[75], 11% of ICU patients receive futile care, defined as medical interventions unlikely to provide meaningful benefit for critically ill patients. These patients often had prolonged stays (up to 58 days), causing overcrowding in the ICU, and 85% died within 6 months. Overcrowded ICUs are associated with higher rates of cross-contamination, lower staff-to-patient ratios, and reduced adherence to infection control practices, all of which increase infection risks for everyone in the unit[76]. When patients receive prolonged, non-beneficial care such as MV, central line infusions, or dialysis with no expectation of recovery, they are exposed longer to invasive devices and hospital-acquired pathogens[77]. This extended exposure significantly raises their risk of infections such as VAP, CLABSI and CAUTI[75]. This is not merely a burden on individual patients; intensivists have warned that such practices promote antimicrobial resistance, which impedes infection control across the ICU and harms other patients[76]. These findings highlight the need for institutional-level interventions that go beyond bedside protocols. These patients also occupy ICU beds for long periods and overcrowd ICUs. One of the solutions would be to implement ICU triage protocols, admission criteria and decision-aid tools to reduce inappropriate ICU admissions[78]. A study conducted at Wroclaw University Hospital in Poland analyzed ICU protocols aimed at identifying and withholding or withdrawing such futile therapies[79]. In 9% of patients, treatments like cardiopulmonary resuscitation, MV, or renal replacement therapy were deemed medically inappropriate and were either withheld or withdrawn. Importantly, all these patients died during hospitalization, underlining the clinical accuracy of the futility assessments and the ethical shift toward palliative care. It must be noted that effective communication with patient families plays a very important role in implementing these protocols. Systemic measures that support early goals-of-care discussions, palliative care referrals, and appropriate ICU triage can reduce these non-beneficial admissions. Such systemic approaches improve the efficiency and safety of critical care, allowing ICUs to focus resources on patients who are most likely to benefit, while simultaneously reducing infection risks for all[80]. It should be noted that withdrawal of life-sustaining therapies varies significantly across countries depending on legal and cultural frameworks. While withdrawal is universally accepted in brain death, decisions in other scenarios must comply with medicolegal standards, which directly influence ICU length of stay and, consequently, infection risk[81,82]. By reducing prolonged, non-beneficial interventions, systemic strategies such as triage protocols and early palliative care not only optimize ICU resource use but also directly limit infection risk by shortening unnecessary exposure to invasive devices and mitigating cross-contamination associated with overcrowding[83-85].

ICUs can be managed in two ways: In open ICUs, care is provided by the admitting physician from any specialty, who may not always be present; in closed ICUs, a dedicated team led by intensivists oversees patient care around the clock[86]. Recent systematic review and meta-analysis show a clear benefit in many aspects of having a closed type ICU[87]. In addition to organizational structure, the physical design of the ICU environment also plays a critical role in infection prevention and patient outcomes. Single room ICU design contributes significantly to the reduction of cross transmission of MRD-bacteria. A 2024 systematic review and meta-analysis found that single-patient ICU rooms significantly reduced the acquisition rate of multidrug-resistant organisms (OR = 0.41, 95%CI: 0.23-0.73), as well as overall nosocomial infection and colonization rates, compared to multi-patient rooms[88]. Adequate nurse-to-patient ratios are associated with reduced risk of VAP, CLABSI, and other HAIs[89]. Having a lower nurse-to-patient ratio reduces compliance to patient care infection prevention bundles and reduces quality of care.

Ethical considerations are integral to ICU infection prevention strategies[90]. Prolonged use of invasive interventions should be carefully evaluated to avoid unnecessary exposure to infection risks and align with patient-centered values of beneficence and non-maleficence[91]. In this context, early integration of palliative care and transparent communication with families are essential[92]. Nursing leadership has a pivotal role in embedding infection prevention into everyday practice, advocating for adequate staffing ratios, ensuring protocol adherence, and fostering a culture of safety that balances patient autonomy, family involvement, and infection control priorities[9].

While the preceding sections outline evidence-based staff-level, patient-level, and systemic interventions, translating these strategies into routine nursing practice requires concise and actionable guidance. To this end, a quick-start checklist of practical nursing actions is provided (Table 4), synthesizing the most relevant measures into a tool designed to support consistent implementation at the bedside.

Table 4 Nursing quick-start checklist for intensive care unit infection prevention.
Domain
Practical nursing actions
Hand hygienePerform hand hygiene at all WHO 5 Moments; ensure alcohol-based rub available at bedside
Personal protective equipmentCorrect donning/doffing; use mask/respirator for aerosol-generating procedures
Invasive devicesVerify daily necessity of central lines, urinary catheters, and ventilators; request removal when no longer indicated
Ventilator careElevate head of bed 30°-45°; provide daily sedation interruption and readiness-to-wean assessment
Oral care and mobilizationPerform oral care with toothbrushing (no chlorhexidine); assist early mobilization/exercise at least once daily
Catheter careUse aseptic technique during insertion; reassess and document catheter necessity daily
Environmental hygieneDisinfect stethoscopes and mobile devices once per shift; ensure clean uniforms and bare forearms
Audit and feedbackParticipate in hand hygiene/device audits; provide and accept immediate feedback
Family/patient engagementEducate families on hand hygiene before and after patient contact; encourage participation in infection-prevention routines
DISCUSSION

This narrative review summarizes the most recent evidence on prevention of hospital acquired ICU infections. These infections are effectively driven by prolonged exposure to invasive devices and the immunocompromised state of critically ill patients. Prevention efforts rely on a multifaceted strategy combining healthcare staff precautions, patient-focused practices, and institutional protocols. Key elements include rigorous hand hygiene, proper use of PPE, and immunization of ICU personnel, all reinforced through structured training, audits, and feedback. These interventions aim to minimize infection transmission risks by targeting both behavioral and organizational factors.

Two recent studies support the prevention strategies outlined in this review. In a recent systematic review Hajiyeva et al[93] examined different studies on quality management interventions for reducing HAI. They found that structured, multifaceted approaches, especially those combining education, protocol standardization, audit-feedback cycles, and leadership involvement, were most effective when embedded into hospital-wide quality systems. Similarly, Schinas et al[94] proposed a five-pillar strategy for reducing multidrug-resistant bacterial transmission in ICUs. These pillars include hygiene promotion, patient management, surveillance, antimicrobial stewardship, and institutional leadership. The authors emphasized that technical solutions alone are insufficient without behavioral change, multidisciplinary collaboration, and organizational support. Together, these studies confirm the core thesis of this review: ICU infection prevention requires coordinated, sustained, and system-level interventions to achieve measurable and lasting impact.

Global experience demonstrates that preventing ICU-acquired infections is not primarily limited by knowledge of effective measures, but by the challenges of translating evidence into sustainable practice. Hand hygiene, PPE use, and care bundles are universally recommended, yet compliance remains inconsistent: In some low- and middle-income countries, adherence falls below 10%, reflecting supply chain instability and infrastructural deficits[95,96], while in high-income countries, audit-driven improvements are often undermined by staff turnover, workload, and “audit fatigue” once monitoring is relaxed[7,97]. Systemic solutions such as closed ICUs or single-patient rooms are effective but often limited by cost and staffing, while real progress can still be made through strong organizational culture and leadership. Importantly, interventions carry trade-offs that complicate implementation: Minimizing sedation reduces ventilator-associated pneumonia but increases unplanned extubations; head-of-bed elevation lowers pneumonia rates but heightens pressure-ulcer risk. These examples underscore that infection prevention is not a checklist of technical tasks but an adaptive process requiring alignment of protocols with local epidemiology, workforce capacity, and organizational culture. Sustainable solutions therefore depend on leadership engagement, multidisciplinary collaboration, and tailoring strategies to context, whether by introducing low-cost checklists and locally produced alcohol rub in resource-limited settings, or by embedding real-time electronic monitoring and structured palliative care pathways in high-resource ICUs. Only by integrating behavioral, ethical, and systemic dimensions can infection prevention programs achieve durable global impact.

A key finding of this review is that successful infection prevention depends on aligning evidence-based protocols with day-to-day ICU practice. This includes staff-level behaviors (e.g., hand hygiene, PPE use), technical interventions (e.g., catheter care), and systemic policies (e.g., triage criteria, closed ICU models). Interventions such as staff immunization and personal device decontamination, though less emphasized in older literature, are emerging as relevant and practical additions.

The unique contribution of this narrative review is its structured synthesis that integrates staff-level, patient-level, and systemic interventions. While previous reports often addressed these domains separately, this review underscores their interdependence and emphasizes that sustainable infection prevention requires their coordinated implementation.

There are several limitations to this manuscript. As a narrative review, it lacks the methodological rigor of a systematic review and may be subject to selection bias. Heterogeneity in implementation settings limits generalizability. However, its strengths include integration of high-quality recent evidence and its structured focus on distinct domains of infection prevention, offering actionable insights for ICU teams.

CONCLUSION

HAI in the ICU are best prevented through a coordinated approach that integrates staff-level precautions, patient-focused bundles, and systemic institutional measures. Sustained progress depends on embedding these strategies into routine workflows, reinforced by auditing, feedback, and leadership support. Core practices include strict hand hygiene, correct PPE use, vaccination of healthcare personnel, and daily reassessment of invasive devices, complemented by care bundles for ventilator-associated pneumonia, CLABSI, and CAUTI. At the systemic level, closed ICU models, single-patient rooms, adequate nurse-to-patient ratios, and triage protocols that avoid futile care reduce overcrowding and unnecessary pathogen exposure. Nursing teams are essential partners in operationalizing checklists, monitoring adherence, and fostering a culture of safety that extends to patient and family engagement. Ethical considerations, such as early goals-of-care discussions and integration of palliative care, further align infection prevention with patient-centered values. Future work should focus on multicenter quality improvement initiatives and local adaptation of existing frameworks, including those from the WHO, CDC, IDSA, SHEA, and other professional societies, to ensure sustainable and globally applicable strategies.

References
1.  Rosenthal VD, Yin R, Nercelles P, Rivera-Molina SE, Jyoti S, Dongol R, Aguilar-De-Moros D, Tumu N, Alarcon-Rua J, Stagnaro JP, Alkhawaja S, Jimenez-Alvarez LF, Cano-Medina YA, Valderrama-Beltran SL, Henao-Rodas CM, Zuniga-Chavarria MA, El-Kholy A, Agha HM, Sahu S, Anusandhan SO, Bhattacharyya M, Kharbanda M, Poojary A, Nair PK, Myatra SN, Chawla R, Sandhu K, Mehta Y, Rajhans P, Zand F, Abdellatif-Daboor M, Tai CW, Gan CS, Mat Nor MB, Aguirre-Avalos G, Hernandez-Chena BE, Sassoe-Gonzalez A, Villegas-Mota I, Aleman-Bocanegra MC, Bat-Erdene I, Carreazo NY, Castaneda-Sabogal A, Janc J, Belskiy V, Hlinkova S, Yildizdas D, Havan M, Koker A, Sungurtekin H, Dinleyici EC, Guclu E, Tao L, Memish ZA, Jin Z. International Nosocomial Infection Control Consortium (INICC) report of health care associated infections, data summary of 45 countries for 2015 to 2020, adult and pediatric units, device-associated module. Am J Infect Control. 2024;52:1002-1011.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 4]  [Cited by in RCA: 34]  [Article Influence: 17.0]  [Reference Citation Analysis (0)]
2.  Gastmeier P, Kola A, Schwab F, Behnke M, Geffers C. Etiology of nosocomial infections in intensive care patients in German hospitals: An analysis of trends between 2008 and 2022. Int J Med Microbiol. 2024;314:151594.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1]  [Cited by in RCA: 10]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
3.  Vincent JL, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, Finfer S, Pelosi P, Brazzi L, Aditianingsih D, Timsit JF, Du B, Wittebole X, Máca J, Kannan S, Gorordo-Delsol LA, De Waele JJ, Mehta Y, Bonten MJM, Khanna AK, Kollef M, Human M, Angus DC; EPIC III Investigators. Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017. JAMA. 2020;323:1478-1487.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 250]  [Cited by in RCA: 609]  [Article Influence: 101.5]  [Reference Citation Analysis (0)]
4.  Gouel-Cheron A, Swihart BJ, Warner S, Mathew L, Strich JR, Mancera A, Follmann D, Kadri SS. Epidemiology of ICU-Onset Bloodstream Infection: Prevalence, Pathogens, and Risk Factors Among 150,948 ICU Patients at 85 U.S. Hospitals. Crit Care Med. 2022;50:1725-1736.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 15]  [Cited by in RCA: 45]  [Article Influence: 11.3]  [Reference Citation Analysis (0)]
5.  O'Grady NP. Prevention of Central Line-Associated Bloodstream Infections. N Engl J Med. 2023;389:1121-1131.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 39]  [Cited by in RCA: 53]  [Article Influence: 17.7]  [Reference Citation Analysis (0)]
6.  Osman MF, Askari R. Infection control in the intensive care unit. Surg Clin North Am. 2014;94:1175-1194.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 17]  [Cited by in RCA: 21]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
7.  Trivedi KK, Schaffzin JK, Deloney VM, Aureden K, Carrico R, Garcia-Houchins S, Garrett JH Jr, Glowicz J, Lee GM, Maragakis LL, Moody J, Pettis AM, Saint S, Schweizer ML, Yokoe DS, Berenholtz S. Implementing strategies to prevent infections in acute-care settings. Infect Control Hosp Epidemiol. 2023;44:1232-1246.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 5]  [Cited by in RCA: 13]  [Article Influence: 4.3]  [Reference Citation Analysis (0)]
8.  Zingg W, Holmes A, Dettenkofer M, Goetting T, Secci F, Clack L, Allegranzi B, Magiorakos AP, Pittet D; systematic review and evidence-based guidance on organization of hospital infection control programmes (SIGHT) study group. Hospital organisation, management, and structure for prevention of health-care-associated infection: a systematic review and expert consensus. Lancet Infect Dis. 2015;15:212-224.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 360]  [Cited by in RCA: 313]  [Article Influence: 28.5]  [Reference Citation Analysis (0)]
9.  McAlearney AS, Gaughan AA, DePuccio MJ, MacEwan SR, Hebert C, Walker DM. Management practices for leaders to promote infection prevention: Lessons from a qualitative study. Am J Infect Control. 2021;49:536-541.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 9]  [Cited by in RCA: 25]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
10.  Oliveira RMC, de Sousa AHF, de Salvo MA, Petenate AJ, Gushken AKF, Ribas E, Torelly EMS, Silva KCCD, Bass LM, Tuma P, Borem P, Ue LY, de Barros CG, Vernal S; Saúde em Nossas Mãos Collaborative Study Group. Estimating the savings of a national project to prevent healthcare-associated infections in intensive care units. J Hosp Infect. 2024;143:8-17.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 9]  [Reference Citation Analysis (0)]
11.  Tomczyk S, Twyman A, de Kraker MEA, Coutinho Rehse AP, Tartari E, Toledo JP, Cassini A, Pittet D, Allegranzi B. The first WHO global survey on infection prevention and control in health-care facilities. Lancet Infect Dis. 2022;22:845-856.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 3]  [Cited by in RCA: 88]  [Article Influence: 22.0]  [Reference Citation Analysis (0)]
12.  Murni IK, Duke T, Kinney S, Daley AJ, Laksanawati IS, Nurnaningsih, Rusmawatiningtyas D, Wirawan MT, Soenarto Y. Multifaceted interventions for healthcare-associated infections and rational use of antibiotics in a low-to-middle-income country: Can they be sustained? PLoS One. 2020;15:e0234233.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 3]  [Cited by in RCA: 6]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
13.  Iroz CB, Ramaswamy R, Bhutta ZA, Barach P. Quality improvement in public-private partnerships in low- and middle-income countries: a systematic review. BMC Health Serv Res. 2024;24:332.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 10]  [Reference Citation Analysis (0)]
14.  Lambe KA, Lydon S, Madden C, Vellinga A, Hehir A, Walsh M, O'Connor P. Hand Hygiene Compliance in the ICU: A Systematic Review. Crit Care Med. 2019;47:1251-1257.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 56]  [Cited by in RCA: 113]  [Article Influence: 18.8]  [Reference Citation Analysis (0)]
15.  Guerrero-Soler M, Gras-Valentí P, Gómez-Sotero IL, Platas-Abenza G, Silva-Afonso RF, Benito-Miralles CM, Fuster-Pérez M, Cartagena-Llopis L, Sánchez-Valero M, Sánchez-Payá J, Chico-Sánchez P. Impact of COVID-19 on the degree of compliance with hand hygiene: a repeated cross-sectional study. Epidemiol Infect. 2024;152:e69.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 6]  [Reference Citation Analysis (0)]
16.  Rüfenacht S, Kohler P, Kuhn R, Flury D, Widmer AF, Schlegel M; Swissnoso. Impact of the coronavirus disease 2019 (COVID-19) pandemic on the adherence to hand hygiene practice in hospitals-Data from a Swiss national surveillance system. Infect Control Hosp Epidemiol. 2023;44:1522-1525.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1]  [Cited by in RCA: 5]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
17.  Alsubaie S, Maither Ab, Alalmaei W, Al-Shammari AD, Tashkandi M, Somily AM, Alaska A, BinSaeed AA. Determinants of hand hygiene noncompliance in intensive care units. Am J Infect Control. 2013;41:131-135.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 37]  [Cited by in RCA: 42]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
18.  Chang NN, Reisinger HS, Schweizer ML, Jones I, Chrischilles E, Chorazy M, Huskins C, Herwaldt L. Hand Hygiene Compliance at Critical Points of Care. Clin Infect Dis. 2021;72:814-820.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 8]  [Cited by in RCA: 25]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
19.  Chou DT, Achan P, Ramachandran M. The World Health Organization '5 moments of hand hygiene': the scientific foundation. J Bone Joint Surg Br. 2012;94:441-445.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 29]  [Cited by in RCA: 44]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
20.  Glowicz JB, Landon E, Sickbert-Bennett EE, Aiello AE, deKay K, Hoffmann KK, Maragakis L, Olmsted RN, Polgreen PM, Trexler PA, VanAmringe MA, Wood AR, Yokoe D, Ellingson KD. SHEA/IDSA/APIC Practice Recommendation: Strategies to prevent healthcare-associated infections through hand hygiene: 2022 Update. Infect Control Hosp Epidemiol. 2023;44:355-376.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 76]  [Reference Citation Analysis (0)]
21.  Blair CJ, McCrudden C, Brazier A, Huf S, Gregory A, O'Driscoll F, Galletly T, Leon-Villapalos C, Brown H, Clay K, Maxwell S, Anakwe R, Grailey K. A helping hand: Applying behavioural science and co-design methodology to improve hand hygiene compliance in the hospital setting. PLoS One. 2024;19:e0310768.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]
22.  Krein SL, Mayer J, Harrod M, Weston LE, Gregory L, Petersen L, Samore MH, Drews FA. Identification and Characterization of Failures in Infectious Agent Transmission Precaution Practices in Hospitals: A Qualitative Study. JAMA Intern Med. 2018;178:1016-1057.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 52]  [Cited by in RCA: 50]  [Article Influence: 6.3]  [Reference Citation Analysis (0)]
23.  Tomas ME, Kundrapu S, Thota P, Sunkesula VC, Cadnum JL, Mana TS, Jencson A, O'Donnell M, Zabarsky TF, Hecker MT, Ray AJ, Wilson BM, Donskey CJ. Contamination of Health Care Personnel During Removal of Personal Protective Equipment. JAMA Intern Med. 2015;175:1904-1910.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 186]  [Cited by in RCA: 199]  [Article Influence: 18.1]  [Reference Citation Analysis (0)]
24.  Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS, Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Crit Care Med. 2020;48:e440-e469.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 634]  [Cited by in RCA: 640]  [Article Influence: 106.7]  [Reference Citation Analysis (0)]
25.  MacIntyre CR, Chughtai AA, Kunasekaran M, Tawfiq E, Greenhalgh T. The role of masks and respirators in preventing respiratory infections in healthcare and community settings. BMJ. 2025;388:e078573.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]
26.  Hasan T, Lynch M, King C, Wehbe C, Plymoth M, Islam MS, Iannuzzi T, Dao A, Lai J, Martiniuk A, Desai S, Sheel M. Vaccine-Preventable Disease Outbreaks Among Healthcare Workers: A Scoping Review. Clin Infect Dis. 2024;79:555-561.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 2]  [Cited by in RCA: 3]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
27.  Sydnor E, Perl TM. Healthcare providers as sources of vaccine-preventable diseases. Vaccine. 2014;32:4814-4822.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 70]  [Cited by in RCA: 83]  [Article Influence: 6.9]  [Reference Citation Analysis (0)]
28.  Young S, Goldin S, Dumolard L, Shendale S, McMurren B, Maltezou HC, Desai S. National vaccination policies for health workers - A cross-sectional global overview. Vaccine. 2024;42:757-769.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 3]  [Cited by in RCA: 5]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
29.  Larese Filon F, Rui F, Ronchese F, De Michieli P, Negro C. Incidence of COVID-19 infection in hospital workers from March 1, 2020 to May 31, 2021 routinely tested, before and after vaccination with BNT162B2. Sci Rep. 2022;12:2533.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 2]  [Cited by in RCA: 14]  [Article Influence: 3.5]  [Reference Citation Analysis (0)]
30.  Lee JT, Sean Hu S, Zhou T, Bonner KE, Kriss JL, Wilhelm E, Carter RJ, Holmes C, de Perio MA, Lu PJ, Nguyen KH, Brewer NT, Singleton JA. Employer requirements and COVID-19 vaccination and attitudes among healthcare personnel in the U.S.: Findings from National Immunization Survey Adult COVID Module, August - September 2021. Vaccine. 2022;40:7476-7482.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 3]  [Cited by in RCA: 20]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
31.  Eltvedt AK, Poulsen A, Winther TN, Von Linstow ML. Barriers for vaccination of healthcare workers. Hum Vaccin Immunother. 2021;17:3073-3076.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 7]  [Reference Citation Analysis (0)]
32.  Olsen M, Nassar R, Senok A, Moloney S, Lohning A, Jones P, Grant G, Morgan M, Palipana D, McKirdy S, Alghafri R, Tajouri L. Mobile phones are hazardous microbial platforms warranting robust public health and biosecurity protocols. Sci Rep. 2022;12:10009.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 1]  [Cited by in RCA: 11]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
33.  Sharew SG, Weldehanna DG, Gebreyes DS, Sahile Z, Abebe TA, Shibabaw A. Extended spectrum betalactamase and carbapenemase producing gram negative bacteria from mobile phones of healthcare workers at Debre Berhan Hospital, Ethiopia. Sci Rep. 2025;15:18427.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 1]  [Reference Citation Analysis (0)]
34.  Simmonds R, Lee D, Hayhurst E. Mobile phones as fomites for potential pathogens in hospitals: microbiome analysis reveals hidden contaminants. J Hosp Infect. 2020;104:207-213.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 18]  [Cited by in RCA: 22]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
35.  Knecht VR, McGinniss JE, Shankar HM, Clarke EL, Kelly BJ, Imai I, Fitzgerald AS, Bittinger K, Bushman FD, Collman RG. Molecular analysis of bacterial contamination on stethoscopes in an intensive care unit. Infect Control Hosp Epidemiol. 2019;40:171-177.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 14]  [Cited by in RCA: 23]  [Article Influence: 2.9]  [Reference Citation Analysis (0)]
36.  Lee R, Choi SM, Jo SJ, Han S, Park YJ, Choi MA, Kong BK. A quasi-experimental study on stethoscopes contamination with multidrug-resistant bacteria: Its role as a vehicle of transmission. PLoS One. 2021;16:e0250455.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 2]  [Cited by in RCA: 9]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
37.  Goyal S, Khot SC, Ramachandran V, Shah KP, Musher DM. Bacterial contamination of medical providers' white coats and surgical scrubs: A systematic review. Am J Infect Control. 2019;47:994-1001.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 23]  [Cited by in RCA: 40]  [Article Influence: 5.7]  [Reference Citation Analysis (0)]
38.  Mitchell A, Spencer M, Edmiston C Jr. Role of healthcare apparel and other healthcare textiles in the transmission of pathogens: a review of the literature. J Hosp Infect. 2015;90:285-292.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 125]  [Cited by in RCA: 104]  [Article Influence: 9.5]  [Reference Citation Analysis (0)]
39.  Haun N, Hooper-Lane C, Safdar N. Healthcare Personnel Attire and Devices as Fomites: A Systematic Review. Infect Control Hosp Epidemiol. 2016;37:1367-1373.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 70]  [Cited by in RCA: 62]  [Article Influence: 6.2]  [Reference Citation Analysis (0)]
40.  Wu L, Tang L, Zhuang L, Xie W, Liu M, Li J. Construction of a standardized training system for hospital infection prevention and control for new medical staff in internal medicine ICUs based on the Delphi method. PLoS One. 2023;18:e0294606.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 1]  [Cited by in RCA: 4]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
41.  Elligsen M, Walker SA, Pinto R, Simor A, Mubareka S, Rachlis A, Allen V, Daneman N. Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients: a controlled interrupted time series analysis. Infect Control Hosp Epidemiol. 2012;33:354-361.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 140]  [Cited by in RCA: 156]  [Article Influence: 11.1]  [Reference Citation Analysis (0)]
42.  Patel PK, Gupta A, Vaughn VM, Mann JD, Ameling JM, Meddings J. Review of Strategies to Reduce Central Line-Associated Bloodstream Infection (CLABSI) and Catheter-Associated Urinary Tract Infection (CAUTI) in Adult ICUs. J Hosp Med. 2018;13:105-116.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 36]  [Cited by in RCA: 45]  [Article Influence: 5.6]  [Reference Citation Analysis (0)]
43.  Anguraj S, Ketan P, Sivaradjy M, Shanmugam L, Jamir I, Cherian A, Sankar Sastry A. The effect of hand hygiene audit in COVID intensive care units in a tertiary care hospital in South India. Am J Infect Control. 2021;49:1247-1251.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 2]  [Cited by in RCA: 14]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
44.  Hixson R, Jensen KS, Melamed KH, Qadir N. Device associated complications in the intensive care unit. BMJ. 2024;386:e077318.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 4]  [Reference Citation Analysis (0)]
45.  Lavallée JF, Gray TA, Dumville J, Russell W, Cullum N. The effects of care bundles on patient outcomes: a systematic review and meta-analysis. Implement Sci. 2017;12:142.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 139]  [Cited by in RCA: 159]  [Article Influence: 17.7]  [Reference Citation Analysis (0)]
46.  Aboelela SW, Stone PW, Larson EL. Effectiveness of bundled behavioural interventions to control healthcare-associated infections: a systematic review of the literature. J Hosp Infect. 2007;66:101-108.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 108]  [Cited by in RCA: 110]  [Article Influence: 5.8]  [Reference Citation Analysis (0)]
47.  Li W, Cai J, Ding L, Chen Y, Wang X, Xu H. Incidence and risk factors of ventilator-associated pneumonia in the intensive care unit: a systematic review and meta-analysis. J Thorac Dis. 2024;16:5518-5528.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 11]  [Reference Citation Analysis (0)]
48.  Klompas M, Branson R, Cawcutt K, Crist M, Eichenwald EC, Greene LR, Lee G, Maragakis LL, Powell K, Priebe GP, Speck K, Yokoe DS, Berenholtz SM. Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2022;43:687-713.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 62]  [Cited by in RCA: 193]  [Article Influence: 48.3]  [Reference Citation Analysis (0)]
49.  Wen J, Ding X, Liu C, Jiang W, Xu Y, Wei X, Liu X. A comparation of dexmedetomidine and midazolam for sedation in patients with mechanical ventilation in ICU: A systematic review and meta-analysis. PLoS One. 2023;18:e0294292.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 14]  [Reference Citation Analysis (0)]
50.  Ehrenzeller S, Klompas M. Association Between Daily Toothbrushing and Hospital-Acquired Pneumonia: A Systematic Review and Meta-Analysis. JAMA Intern Med. 2024;184:131-142.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 31]  [Cited by in RCA: 29]  [Article Influence: 14.5]  [Reference Citation Analysis (0)]
51.  Jiroutková K, Duška F, Waldauf P. Should New Data on Rehabilitation Interventions in Critically Ill Patients Change Clinical Practice? Updated Meta-Analysis of Randomized Controlled Trials. Crit Care Med.  2024.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 8]  [Reference Citation Analysis (0)]
52.  Wu RY, Yeh HJ, Chang KJ, Tsai MW. Effects of different types and frequencies of early rehabilitation on ventilator weaning among patients in intensive care units: A systematic review and meta-analysis. PLoS One. 2023;18:e0284923.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 17]  [Reference Citation Analysis (0)]
53.  Lian C, Zhang J, Wang P, Mao W. Impact of head-of-bed elevation angle on the development of pressure ulcers and pneumonia in patients on mechanical ventilation: a systematic review and meta-analysis. BMC Pulm Med. 2024;24:462.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 4]  [Reference Citation Analysis (0)]
54.  Ouellette DR, Patel S, Girard TD, Morris PE, Schmidt GA, Truwit JD, Alhazzani W, Burns SM, Epstein SK, Esteban A, Fan E, Ferrer M, Fraser GL, Gong MN, Hough CL, Mehta S, Nanchal R, Pawlik AJ, Schweickert WD, Sessler CN, Strøm T, Kress JP. Liberation From Mechanical Ventilation in Critically Ill Adults: An Official American College of Chest Physicians/American Thoracic Society Clinical Practice Guideline: Inspiratory Pressure Augmentation During Spontaneous Breathing Trials, Protocols Minimizing Sedation, and Noninvasive Ventilation Immediately After Extubation. Chest. 2017;151:166-180.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 163]  [Cited by in RCA: 243]  [Article Influence: 24.3]  [Reference Citation Analysis (0)]
55.  Artime CA, Hagberg CA. Tracheal extubation. Respir Care. 2014;59:991-1002; discussion 1002.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 33]  [Cited by in RCA: 42]  [Article Influence: 3.5]  [Reference Citation Analysis (0)]
56.  Teja B, Bosch NA, Diep C, Pereira TV, Mauricio P, Sklar MC, Sankar A, Wijeysundera HC, Saskin R, Walkey A, Wijeysundera DN, Wunsch H. Complication Rates of Central Venous Catheters: A Systematic Review and Meta-Analysis. JAMA Intern Med. 2024;184:474-482.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 18]  [Cited by in RCA: 93]  [Article Influence: 46.5]  [Reference Citation Analysis (0)]
57.  Buetti N, Marschall J, Drees M, Fakih MG, Hadaway L, Maragakis LL, Monsees E, Novosad S, O'Grady NP, Rupp ME, Wolf J, Yokoe D, Mermel LA. Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2022;43:553-569.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 13]  [Cited by in RCA: 229]  [Article Influence: 57.3]  [Reference Citation Analysis (0)]
58.  Parienti JJ, Mongardon N, Mégarbane B, Mira JP, Kalfon P, Gros A, Marqué S, Thuong M, Pottier V, Ramakers M, Savary B, Seguin A, Valette X, Terzi N, Sauneuf B, Cattoir V, Mermel LA, du Cheyron D; 3SITES Study Group. Intravascular Complications of Central Venous Catheterization by Insertion Site. N Engl J Med. 2015;373:1220-1229.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 401]  [Cited by in RCA: 497]  [Article Influence: 45.2]  [Reference Citation Analysis (0)]
59.  Eggimann P, Pagani JL, Dupuis-Lozeron E, Ms BE, Thévenin MJ, Joseph C, Revelly JP, Que YA. Sustained reduction of catheter-associated bloodstream infections with enhancement of catheter bundle by chlorhexidine dressings over 11 years. Intensive Care Med. 2019;45:823-833.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 24]  [Cited by in RCA: 30]  [Article Influence: 4.3]  [Reference Citation Analysis (0)]
60.  Fordyce CB, Katz JN, Alviar CL, Arslanian-Engoren C, Bohula EA, Geller BJ, Hollenberg SM, Jentzer JC, Sims DB, Washam JB, van Diepen S; American Heart Association Council on Clinical Cardiology;  Council on Arteriosclerosis, Thrombosis and Vascular Biology;  Council on Cardiovascular and Stroke Nursing;  Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation;  and Stroke Council. Prevention of Complications in the Cardiac Intensive Care Unit: A Scientific Statement From the American Heart Association. Circulation. 2020;142:e379-e406.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 12]  [Cited by in RCA: 70]  [Article Influence: 11.7]  [Reference Citation Analysis (0)]
61.  Yin R, Jin Z, Lee BH, Alvarez GA, Stagnaro JP, Valderrama-Beltran SL, Gualtero SM, Jiménez-Alvarez LF, Reyes LP, Henao Rodas CM, Gomez K, Alarcon J, Aguilar Moreno LA, Bravo Ojeda JS, Cano Medina YA, Chapeta Parada EG, Zuniga Chavarria MA, Quesada Mora AM, Aguirre-Avalos G, Mijangos-Méndez JC, Sassoe-Gonzalez A, Millán-Castillo CM, Aleman-Bocanegra MC, Echazarreta-Martínez CV, Hernandez-Chena BE, Jarad RMA, Villegas-Mota MI, Montoya-Malváez M, Aguilar-de-Moros D, Castaño-Guerra E, Córdoba J, Castañeda-Sabogal A, Medeiros EA, Fram D, Dueñas L, Carreazo NY, Salgado E, Rosenthal VD. Prospective cohort study of incidence and risk factors for catheter-associated urinary tract infections in 145 intensive care units of 9 Latin American countries: INICC findings. World J Urol. 2023;41:3599-3609.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]
62.  Tomazini BM, Besen BAMP, Santos RHN, Nassar AP Jr, Veiga TS, Campos VB, Tokunaga SM, Santos ES, Barbante LG, da Costa Maia R, Kojima FCS, Laranjeira LN, Taniguchi LU, Roepke RML, Franke CA, Sanches LC, Melro LMG, Maia IS, de Souza Dantas VC, Figueiredo RC, de Alencar Filho MS, Irineu VM, Lovato WJ, Zandonai CL, Machado FR, Arns B, Marsola G, Veiga VC, Pereira AJ, Cavalcanti AB; IMPACTO-MR investigators (2019 - 2023);  BRICNet. Clinical impact of healthcare-associated infections in Brazilian ICUs: a multicenter prospective cohort. Crit Care. 2025;29:4.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 3]  [Reference Citation Analysis (0)]
63.  Rabi R, Enaya A, Jomaa DM, Dweekat MZ, Raddad S, Saqfalhait ZT, Abu-Gaber D. Catheter-associated urinary tract infections in critical care: Understanding incidence, risk factors, and pathogenic causes in Palestine. PLoS One. 2024;19:e0309755.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 5]  [Reference Citation Analysis (0)]
64.  Patel PK, Advani SD, Kofman AD, Lo E, Maragakis LL, Pegues DA, Pettis AM, Saint S, Trautner B, Yokoe DS, Meddings J. Strategies to prevent catheter-associated urinary tract infections in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2023;44:1209-1231.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 57]  [Reference Citation Analysis (0)]
65.  Saint S, Greene MT, Kowalski CP, Watson SR, Hofer TP, Krein SL. Preventing catheter-associated urinary tract infection in the United States: a national comparative study. JAMA Intern Med. 2013;173:874-879.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 92]  [Cited by in RCA: 96]  [Article Influence: 7.4]  [Reference Citation Analysis (0)]
66.  Fink R, Gilmartin H, Richard A, Capezuti E, Boltz M, Wald H. Indwelling urinary catheter management and catheter-associated urinary tract infection prevention practices in Nurses Improving Care for Healthsystem Elders hospitals. Am J Infect Control. 2012;40:715-720.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 48]  [Cited by in RCA: 52]  [Article Influence: 3.7]  [Reference Citation Analysis (0)]
67.  Mody L, Greene MT, Meddings J, Krein SL, McNamara SE, Trautner BW, Ratz D, Stone ND, Min L, Schweon SJ, Rolle AJ, Olmsted RN, Burwen DR, Battles J, Edson B, Saint S. A National Implementation Project to Prevent Catheter-Associated Urinary Tract Infection in Nursing Home Residents. JAMA Intern Med. 2017;177:1154-1162.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 64]  [Cited by in RCA: 82]  [Article Influence: 9.1]  [Reference Citation Analysis (0)]
68.  Shuman EK, Chenoweth CE. Recognition and prevention of healthcare-associated urinary tract infections in the intensive care unit. Crit Care Med. 2010;38:S373-S379.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 51]  [Cited by in RCA: 42]  [Article Influence: 2.6]  [Reference Citation Analysis (0)]
69.  Boehm LM, Dietrich MS, Vasilevskis EE, Wells N, Pandharipande P, Ely EW, Mion LC. Perceptions of Workload Burden and Adherence to ABCDE Bundle Among Intensive Care Providers. Am J Crit Care. 2017;26:e38-e47.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 39]  [Cited by in RCA: 50]  [Article Influence: 5.6]  [Reference Citation Analysis (0)]
70.  Alp E, Cookson B, Erdem H, Rello J; Survey Group. Infection control bundles in intensive care: an international cross-sectional survey in low- and middle-income countries. J Hosp Infect. 2019;101:248-256.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 14]  [Cited by in RCA: 20]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
71.  Klompas M, Li L, Kleinman K, Szumita PM, Massaro AF. Associations Between Ventilator Bundle Components and Outcomes. JAMA Intern Med. 2016;176:1277-1283.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 73]  [Cited by in RCA: 101]  [Article Influence: 10.1]  [Reference Citation Analysis (0)]
72.  Green SA, Bell D, Mays N. Identification of factors that support successful implementation of care bundles in the acute medical setting: a qualitative study. BMC Health Serv Res. 2017;17:120.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 18]  [Cited by in RCA: 33]  [Article Influence: 3.7]  [Reference Citation Analysis (0)]
73.  Brockman A, Krupp A, Bach C, Mu J, Vasilevskis EE, Tan A, Mion LC, Balas MC. Clinicians' perceptions on implementation strategies used to facilitate ABCDEF bundle adoption: A multicenter survey. Heart Lung. 2023;62:108-115.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 2]  [Cited by in RCA: 7]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
74.  Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K; EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323-2329.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 2205]  [Cited by in RCA: 2418]  [Article Influence: 142.2]  [Reference Citation Analysis (0)]
75.  Huynh TN, Kleerup EC, Wiley JF, Savitsky TD, Guse D, Garber BJ, Wenger NS. The frequency and cost of treatment perceived to be futile in critical care. JAMA Intern Med. 2013;173:1887-1894.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 148]  [Cited by in RCA: 168]  [Article Influence: 12.9]  [Reference Citation Analysis (0)]
76.  Niederman MS, Berger JT. The delivery of futile care is harmful to other patients. Crit Care Med. 2010;38:S518-S522.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 42]  [Cited by in RCA: 45]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
77.  Buetti N, Ruckly S, Souweine B, Mimoz O, Timsit JF. Risk of infections in intravascular catheters in situ for more than 10 days: a post hoc analysis of randomized controlled trials. Clin Microbiol Infect. 2023;29:1200.e1-1200.e5.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 8]  [Reference Citation Analysis (0)]
78.  Larangeira AS, Mezzaroba AL, Morakami FK, Cardoso LTQ, Matsuo T, Grion CMC. Improved performance of an intensive care unit after changing the admission triage model. Sci Rep. 2023;13:17043.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 1]  [Reference Citation Analysis (0)]
79.  Woźnica-Niesobska E, Goździk W, Śmiechowicz J, Stróżecki Ł, Kubler A. Analysis of management protocols regarding ineffective maintenance of organ functions in patients treated at the Intensive Care Unit of the University Hospital in Wroclaw. Anaesthesiol Intensive Ther. 2020;52:3-9.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1]  [Cited by in RCA: 4]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
80.  Khandelwal N, Long AC, Lee RY, McDermott CL, Engelberg RA, Curtis JR. Pragmatic methods to avoid intensive care unit admission when it does not align with patient and family goals. Lancet Respir Med. 2019;7:613-625.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 13]  [Cited by in RCA: 22]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
81.  Greer DM, Shemie SD, Lewis A, Torrance S, Varelas P, Goldenberg FD, Bernat JL, Souter M, Topcuoglu MA, Alexandrov AW, Baldisseri M, Bleck T, Citerio G, Dawson R, Hoppe A, Jacobe S, Manara A, Nakagawa TA, Pope TM, Silvester W, Thomson D, Al Rahma H, Badenes R, Baker AJ, Cerny V, Chang C, Chang TR, Gnedovskaya E, Han MK, Honeybul S, Jimenez E, Kuroda Y, Liu G, Mallick UK, Marquevich V, Mejia-Mantilla J, Piradov M, Quayyum S, Shrestha GS, Su YY, Timmons SD, Teitelbaum J, Videtta W, Zirpe K, Sung G. Determination of Brain Death/Death by Neurologic Criteria: The World Brain Death Project. JAMA. 2020;324:1078-1097.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 194]  [Cited by in RCA: 375]  [Article Influence: 62.5]  [Reference Citation Analysis (0)]
82.  Avidan A, Sprung CL, Schefold JC, Ricou B, Hartog CS, Nates JL, Jaschinski U, Lobo SM, Joynt GM, Lesieur O, Weiss M, Antonelli M, Bülow HH, Bocci MG, Robertsen A, Anstey MH, Estébanez-Montiel B, Lautrette A, Gruber A, Estella A, Mullick S, Sreedharan R, Michalsen A, Feldman C, Tisljar K, Posch M, Ovu S, Tamowicz B, Demoule A, DeKeyser Ganz F, Pargger H, Noto A, Metnitz P, Zubek L, de la Guardia V, Danbury CM, Szűcs O, Protti A, Filipe M, Simpson SQ, Green C, Giannini AM, Soliman IW, Piras C, Caser EB, Hache-Marliere M, Mentzelopoulos SD; ETHICUS-2 Study Group. Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational study. Lancet Respir Med. 2021;9:1101-1110.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 21]  [Cited by in RCA: 105]  [Article Influence: 21.0]  [Reference Citation Analysis (0)]
83.  Nates JL, Nunnally M, Kleinpell R, Blosser S, Goldner J, Birriel B, Fowler CS, Byrum D, Miles WS, Bailey H, Sprung CL. ICU Admission, Discharge, and Triage Guidelines: A Framework to Enhance Clinical Operations, Development of Institutional Policies, and Further Research. Crit Care Med. 2016;44:1553-1602.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 296]  [Cited by in RCA: 416]  [Article Influence: 41.6]  [Reference Citation Analysis (0)]
84.  Chang DW, Neville TH, Parrish J, Ewing L, Rico C, Jara L, Sim D, Tseng CH, van Zyl C, Storms AD, Kamangar N, Liebler JM, Lee MM, Yee HF Jr. Evaluation of Time-Limited Trials Among Critically Ill Patients With Advanced Medical Illnesses and Reduction of Nonbeneficial ICU Treatments. JAMA Intern Med. 2021;181:786-794.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 64]  [Cited by in RCA: 89]  [Article Influence: 17.8]  [Reference Citation Analysis (0)]
85.  Ma J, Chi S, Buettner B, Pollard K, Muir M, Kolekar C, Al-Hammadi N, Chen L, Kollef M, Dans M. Early Palliative Care Consultation in the Medical ICU: A Cluster Randomized Crossover Trial. Crit Care Med. 2019;47:1707-1715.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 55]  [Cited by in RCA: 118]  [Article Influence: 19.7]  [Reference Citation Analysis (0)]
86.  Ko SJ, Cho J, Choi SM, Park YS, Lee CH, Yoo CG, Lee J, Lee SM. Impact of staffing model conversion from a mandatory critical care consultation model to a closed unit model in the medical intensive care unit. PLoS One. 2021;16:e0259092.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]
87.  Vahedian-Azimi A, Rahimibashar F, Ashtari S, Guest PC, Sahebkar A. Comparison of the clinical features in open and closed format intensive care units: A systematic review and meta-analysis. Anaesth Crit Care Pain Med. 2021;40:100950.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 2]  [Cited by in RCA: 10]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
88.  Zhang Z, Tan X, Shi H, Zhao J, Zhang H, Li J, Liao X. Effect of single-patient room design on the incidence of nosocomial infection in the intensive care unit: a systematic review and meta-analysis. Front Med (Lausanne). 2024;11:1421055.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 1]  [Reference Citation Analysis (0)]
89.  Yin Y, Sun M, Li Z, Bu J, Chen Y, Zhang K, Hu Z. Exploring the Nursing Factors Related to Ventilator-Associated Pneumonia in the Intensive Care Unit. Front Public Health. 2022;10:715566.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 9]  [Reference Citation Analysis (0)]
90.  Tan C, Ofner M, Candon HL, Reel K, Bean S, Chan AK, Leis JA. An ethical framework adapted for infection prevention and control. Infect Control Hosp Epidemiol. 2023;44:2044-2049.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 4]  [Cited by in RCA: 5]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
91.  Hwe C, Parrish J, Berry B, Stens O, Chang DW. Nonbeneficial Intensive Care: Misalignments Between Provider Assessments of Benefit and Use of Invasive Treatments. J Intensive Care Med. 2020;35:1411-1417.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1]  [Cited by in RCA: 5]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
92.  Doherty C, Feder S, Gillespie-Heyman S, Akgün KM. Easing Suffering for ICU Patients and Their Families: Evidence and Opportunities for Primary and Specialty Palliative Care in the ICU. J Intensive Care Med. 2024;39:715-732.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 5]  [Cited by in RCA: 11]  [Article Influence: 5.5]  [Reference Citation Analysis (0)]
93.  Hajiyeva A, Jarl J, Saha S. The effectiveness of quality management interventions in reducing hospital-associated infections in adult patients: A systematic literature review. Int J Infect Dis. 2025;154:107837.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 3]  [Reference Citation Analysis (0)]
94.  Schinas G, Polyzou E, Spernovasilis N, Gogos C, Dimopoulos G, Akinosoglou K. Preventing Multidrug-Resistant Bacterial Transmission in the Intensive Care Unit with a Comprehensive Approach: A Policymaking Manual. Antibiotics (Basel). 2023;12:1255.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 18]  [Reference Citation Analysis (0)]
95.  Adal O, Tsehay YT, Ayenew B, Abate TW, Mekonnen GB, Mulatu S, Mamo ST, Ayenew T, Messelu MA, Belayneh AG. The burden and predictors of hospital-acquired infection in intensive care units across Sub-Sahara Africa: systematic review and metanalysis. BMC Infect Dis. 2025;25:634.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 3]  [Reference Citation Analysis (0)]
96.  Igwe U, Okolie OJ, Ismail SU, Adukwu E. Effectiveness of infection prevention and control interventions in health care facilities in Africa: A systematic review. Am J Infect Control. 2024;52:1135-1143.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 11]  [Reference Citation Analysis (0)]
97.  Price L, Gozdzielewska L, Hendry K, McFarland A, Reilly J. Effectiveness of national and subnational interventions for prevention and control of health-care-associated infections in acute hospitals in high-income and upper-middle-income counties: a systematic review update. Lancet Infect Dis. 2023;23:e347-e360.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 5]  [Cited by in RCA: 11]  [Article Influence: 3.7]  [Reference Citation Analysis (0)]
Footnotes

Provenance and peer review: Invited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Critical care medicine

Country of origin: Italy

Peer-review report’s classification

Scientific Quality: Grade A, Grade B, Grade B, Grade B, Grade C

Novelty: Grade B, Grade B, Grade B, Grade C

Creativity or Innovation: Grade B, Grade C, Grade C, Grade D, Grade D

Scientific Significance: Grade B, Grade B, Grade B, Grade C, Grade D

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

P-Reviewer: Pandurangan H, Professor, India; Rai S, MD, Professor, India; Sarac E, PhD, Post Doctoral Researcher, Türkiye S-Editor: Liu H L-Editor: A P-Editor: Zhao YQ